Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial.
Saved in:
| Title: | Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial. |
|---|---|
| Authors: | Privé, Bastiaan M.1 (AUTHOR), Janssen, Marcel J. R.1 (AUTHOR), van Oort, Inge M.2 (AUTHOR), Muselaers, Constantijn H. J.2 (AUTHOR), Jonker, Marianne A.3 (AUTHOR), van Gemert, Willemijn A.1 (AUTHOR), de Groot, Michel1 (AUTHOR), Westdorp, Harm4 (AUTHOR), Mehra, Niven4 (AUTHOR), Verzijlbergen, J. Fred1 (AUTHOR), Scheenen, Tom W. J.1 (AUTHOR), Zámecnik, Patrik1 (AUTHOR), Barentsz, Jelle O.1 (AUTHOR), Gotthardt, Martin1 (AUTHOR), Noordzij, Walter5 (AUTHOR), Vogel, Wouter V.6,7 (AUTHOR), Bergman, Andries M.8 (AUTHOR), van der Poel, Henk G.9 (AUTHOR), Vis, André N.10 (AUTHOR), Oprea-Lager, Daniela E.11 (AUTHOR) |
| Source: | Trials. 11/4/2021, Vol. 22 Issue 1, p1-4. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
